Pellis Care is addressing a $100bn global unmet clinical need in chronic wounds that affect around 100 million people worldwide. The product, PCDFU23, is a novel topical formulation, of an immuno-modulatory molecule with a well-established safety profile, that has shown early signs of efficacy in the treatment of chronic wounds. The Pellis Care management team has extensive experience in research and development, and the regulatory process for pharmaceutical products. Our unique combination of skills and experience is ideal to create potential new therapies and new intellectual property.
Company Details
- Employees
- 5
- Address
- Cambridge, Gb
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.pelliscare.com
- HQ
- Cambridge
Pellis Care Questions
Pellis Care's website is http://www.pelliscare.com
Pellis Care's LinkedIn profile is https://uk.linkedin.com/company/pellis-care
Pellis Care has
5 employees.
View email and phone details for 5
employees at Pellis Care.
Pellis Care's industry is
Pharmaceutical Manufacturing
Pellis Care's top competitors are
Project Farma (Pf),
Matcor-Matsu Group,
Sikorsky,
Advance Tool Co,
Phil Ellis Associates, Inc.,
Five Alarm Bio Limited.
Pellis Care's categories are Pharmaceutical Manufacturing
